#cell 22.1

[got-into-worm-by-mistake]

“Arthropodaudience,” Miss Militia said.  “She’s fully aware of everything that’s been going on in this building.”

Okay, now ya'll just making up words. You can just say 'she hears through bugs'. :rofl: You don't need to come up with a fancy word for every power.

[wormbloggign]

omg he was

clockblocker where is your gaydar? this bi lesbian doesnt have time for your bullshit

actually i guess she does?

i doubt she has anywhere she wants to go in a rush rn

oh wow, this guy really just wants to be as big of a p.o.s as possible, i guess it harmless but it would be nice to see him get undermined by his subordinates in the future

she's a little out of sync with polite society huh

(while police brutality is very much a real thing and prisoners get abused to alarming amounts especially by their guards and wardens, from what i've gleamed of wildbows personal philosophy, i doubt any of that is going to happen here)

that's a solid quip tho, taylors getting better at the more traditional elements of a superpowered persona

(while in the prison, she is functionally able to do cutaway gags)

theyve been stepping around the idea that taylors pregnant a weird amount in this chapter, i hope its just a weird beat and not anything more.

no she can't :)

thats just vindictive man, dont be a dick

an interesting thing to bring up, now that we know more. we can assume that her trigger event at least resonated with the idea that her passenger/guide/consort represents and 2 other events (that i remember) which both involve taylor (notably as herself, not skitter) taking action against people who have been unreasonably vindictive and cruel to her, one could probably argue that her boosting concept is flat Justice, but i doubt that because of the bug motif, specifically the fact it first flared up in a way that wouldnt punish emma but instead, comfort taylor when she needed to ground herself, we also run with her theme of necessity (almost definitely not her boosting concept either) where she goes out of her way to make sure the things that NEED doing are done, far more concerned with what good she can do with power and wealth than wanting it for selfish reasons. at times i feel like she's a well placed bit of oil, lubricating the machine of society (bad metaphor but you get the picture).

with all that i think vindication might be the closest i could get to guessing but that'd still be wrong

i can say though, it doesnt amplify when she feels trapped, it amplifies when she works to escape.

(note, i may have just said nothing with all that, disregard)

i love taylors bug references, 10/10 every time

good for her, its nice to hear she's healing

oooohhhh 98% timeline it is, that's reassuring to hear

aw, you're gonna make her blush

DINAHS ON TOP BABEYY

(it seems she's lucid and has agency, i am proud of her recovery and also her sass)

COMMON (clap emoji) DINAH (clap emoji) W

i think i might hate this guy more than armsmaster, at least he had the excuse that he was trying to do the right thing (sometimes), tagg seemingly just hates capes in all forms and enjoys making people suffer when he can make them, genuinely sickening, shouldn't be allowed near children

taylor was riling up to defend the girl who sentenced her to probably the birdcage, sad that it showed her hand.

that's what i said!

(also, boss move announcing her prescence throughout the building, theyve been fully compromised.)

not mind control, just good, old fashioned lesbianism

funniest counter-argument

L bozo, wrong again

taylors up to her favourite pastime again, SPOT CHECKING GOVERNING BODIES!!

[covid-safer-hotties]

Reference saved in our archive

Masking by hospital staff dropped the instances of respiratory infection during a hospital stay from 22% in patients to just a hair over 2%.

Abstract Patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infections. The consequent use of masks on wards for allo-HSCT has been controversial in the past decades and was not common before the COVID-19 pandemic. We retrospectively compared incidence and outcomes of viral respiratory infections during allo-HSCT on our specialized ward between 01/2018 and 09/2020 to the era of FFP2 masking between 10/2020 and 10/2022 covering similar seasons of the year. Each group consisted of 150 matched patients. The usage of FFP2 masks reduced the incidence of viral respiratory infections from 22.1 to 2.1% (p < 0.005). This reduced the time on ward from a median of 26 days to 23.5 days (p = 0.002). It also resulted in less use of CT-scans (p = 0.003) and bronchoalveolar lavage procedures (p = 0.057). Median time to proof of infection was 21 days after admission in both groups. No difference was detected in progression free survival, hospital survival or non-relapse mortality (p = 0.78). Our retrospective results indicate that FFP2 masks worn by patients and hospital staff may help to significantly reduce the incidence of viral respiratory infections, including COVID-19, shorten the in-hospital time, and reduce costs without affecting survival.

[rebel-sqrrl]

genuine question, when did Taylor get sexually assaulted?

Cell 22.1, she gets cavity searched by a PRT agent

[willyskristina]

Thin Film Solar Cell Market

Thin Film Solar Cell Market Size, Share, Trends: First Solar, Inc. Leads

Integration of Thin Film Solar Cells in Consumer Electronics

Market Overview:

The thin film solar cell market is expected to develop at a CAGR of 12.5% from 2024 to 2031. The market value is predicted to rise from USD XX billion in 2024 to USD YY billion in 2031. Asia-Pacific dominates the market, accounting for the vast majority of worldwide sales. Key metrics include increased use of renewable energy sources, rising demand for building-integrated photovoltaics, and technological breakthroughs in thin-film solar cell efficiency. The market is expanding rapidly due to the global push for clean energy, lower manufacturing costs, and the adaptability of thin-film solar cells in a variety of applications. The industry is transitioning to more efficient and adaptable solar cell technologies, particularly in emerging markets and specialist applications.

DOWNLOAD FREE SAMPLE

Market Trends:

The thin-film solar cell business is expanding rapidly as these cells become more integrated into consumer products. The increased need for portable, self-powered devices, as well as the necessity for sustainable energy solutions in everyday products, are driving this trend. For example, the use of thin-film solar cells in smartphones has resulted in an estimated 15% increase in battery life for outdoor applications. Furthermore, the market for solar-powered wearables, such as smartwatches and fitness trackers, has increased by 30% over the last year, with thin-film solar cells playing a critical role in increasing device autonomy. Thin film solar cells' flexibility and lightweight nature make them perfect for integration into a wide range of consumer devices, creating new market opportunities and driving product design innovation.

Market Segmentation:

The Cadmium Telluride (CdTe) segment dominates the thin film solar cell market, accounting for the largest market share. Cadmium telluride (CdTe) has emerged as the dominant force in the thin film solar cell market, owing to its low cost, high efficiency, and well-established manufacturing techniques. This segment's popularity stems from the technology's ability to provide competitive performance at cheaper costs when compared to other thin film technologies and classic crystalline silicon cells. According to industry experts, CdTe thin film solar cells have attained a record efficiency of 22.1% in laboratory settings, while commercial modules typically achieve efficiencies of 18-19%.

Market Key Players:

The thin film solar cell market is highly competitive, with major players focusing on technological innovation and strategic alliances. Key companies such as First Solar, Inc., Solar Frontier K.K., Hanergy Thin Film Power Group Limited, Ascent Solar Technologies, Inc., Kaneka Corporation, Mitsubishi Electric Corporation, Sharp Corporation, Suntech Power Holdings Co., Ltd., United Solar Ovonic LLC, and Trony Solar Holdings Co., Ltd. dominate the market.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[credenceresearchdotblog]

The Oncology Biosimilars Market is projected to grow from USD 4725 million in 2024 to an estimated USD 23341.41 million by 2032, with a compound annual growth rate (CAGR) of 22.1% from 2024 to 2032. The oncology biosimilars market is rapidly emerging as a key segment in the biopharmaceutical industry. With increasing cases of cancer globally and the rising costs of innovative biologics, oncology biosimilars offer a cost-effective alternative while ensuring similar safety and efficacy profiles. This article delves into the market dynamics, trends, challenges, and future prospects of oncology biosimilars.

Browse the full report  https://www.credenceresearch.com/report/oncology-biosimilars-market

Understanding Oncology Biosimilars

Biosimilars are biologic medical products that are highly similar to an already approved reference product, with no clinically meaningful differences in terms of safety, efficacy, or quality. In oncology, biosimilars address various cancers such as breast cancer, colorectal cancer, non-small cell lung cancer, and lymphoma. They replicate biologics like monoclonal antibodies and growth factors used in cancer treatment and supportive care.

Market Growth Drivers

1. Rising Cancer Incidence: According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, with an estimated 20 million new cases in 2022 alone. This growing disease burden amplifies the demand for cost-effective treatment options, making oncology biosimilars a critical component of cancer care.

2. Cost-Effectiveness: Biosimilars are priced approximately 15-30% lower than their reference biologics, offering significant savings for healthcare systems and patients. This affordability is particularly impactful in low- and middle-income countries where access to expensive biologics is limited.

3. Patent Expirations: Several blockbuster oncology biologics, including trastuzumab (Herceptin) and bevacizumab (Avastin), have lost patent protection in recent years. This has paved the way for the entry of biosimilars, driving market competition and adoption.

4. Regulatory Support: Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have established clear guidelines for the approval of biosimilars, encouraging pharmaceutical companies to invest in their development.

Key Market Trends

1. Expanding Product Portfolio: The oncology biosimilars market is witnessing an expansion in product offerings. Biosimilars for blockbuster drugs such as rituximab, pegfilgrastim, and cetuximab are gaining traction, with multiple players entering the space.

2. Increasing Approvals and Launches: Over the past decade, the FDA and EMA have approved numerous oncology biosimilars, including biosimilars for trastuzumab (e.g., Ogivri, Herzuma) and bevacizumab (e.g., Zirabev, Mvasi). These approvals have bolstered the market and enhanced access to affordable cancer treatments.

3. Collaborations and Partnerships: Pharmaceutical companies are increasingly entering strategic collaborations to enhance biosimilar development and commercialization. Partnerships between biotech firms, contract research organizations, and healthcare providers are streamlining market entry and expanding distribution networks.

4. Rising Acceptance Among Physicians: Initial skepticism surrounding biosimilars is gradually fading as real-world evidence demonstrates their safety and efficacy. Educational initiatives and clinical data are fostering confidence among oncologists and patients.

Challenges in the Market

1. Regulatory and Development Complexity: Developing biosimilars involves sophisticated processes and significant investment. Ensuring similarity in structure, function, and clinical outcomes with the reference biologic is challenging and time-consuming.

2. Market Competition: While competition drives innovation, it also exerts pressure on pricing and profitability. Companies must adopt innovative pricing strategies and differentiation approaches to capture market share.

3. Physician and Patient Perception: Despite increasing acceptance, some healthcare providers and patients remain cautious about switching from biologics to biosimilars. Addressing these concerns through education and robust clinical evidence is crucial.

Future Outlook

The oncology biosimilars market is poised for exponential growth, driven by factors like rising cancer prevalence, supportive regulatory frameworks, and ongoing technological advancements. By 2030, the market is expected to reach significant valuations, with Asia-Pacific and emerging markets playing a pivotal role due to their large patient populations and cost-sensitive healthcare systems.

Moreover, advancements in biosimilar manufacturing, including the use of artificial intelligence and machine learning, promise to reduce development timelines and costs. Governments and healthcare organizations worldwide are also likely to continue promoting biosimilar adoption through favorable policies and reimbursement frameworks.

Key Player Analysis:

Allergan (Ireland)

Amneal Pharmaceuticals LLC. (U.S.)

Apotex Inc. (Canada)

Aurobindo Pharma (India)

BIOCAD (Russia)

Bristol-Myers Squibb Company (U.S.)

Cipla Inc. (U.S.)

Eli Lilly and Company (U.S.)

Endo International plc (Ireland)

Hoffmann-La Roche Ltd. (Switzerland)

GlaxoSmithKline plc (U.K.)

Glenmark Pharmaceuticals Limited (India)

Lupin (India)

Mylan N.V. (U.S.)

Novartis AG (Switzerland)

Pfizer Inc. (U.S.)

Sanofi (France)

Sun Pharmaceutical Industries Ltd. (India)

Takeda Pharmaceutical Company Limited (Japan)

Teva Pharmaceutical Industries Ltd.(Israel)

Zydus Cadila (India)

Segmentation:

By Drug

G-CSF

Monoclonal Antibody

Hematopoietic Agents

By Disease Indication

Breast Cancer

Non-Small Cell Lung Cancer

Colorectal Cancer

Neutropenia

Blood Cancer

Leukemia

Myeloid Leukemia

Chronic Lymphocytic Leukemia (CLL)

Non-Hodgkin Lymphoma

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

By Regional

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report  https://www.credenceresearch.com/report/oncology-biosimilars-market

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[chemicalmarketwatch-sp]

The Global Market for Metal Organic Frameworks (MOFs): Current Trends, Challenges, and Future Opportunities

Metal Organic Frameworks (MOFs) are gaining substantial attention as a new class of advanced materials with immense potential across various industries. These hybrid materials, composed of metal ions and organic linkers, exhibit unique properties such as high porosity and tunable structures, making them suitable for a wide range of applications, including gas storage, separation technologies, catalysis, and drug delivery. As the MOF industry continues to grow, it is crucial for industry leaders to understand the key trends and challenges shaping the market. This article provides an in-depth analysis of the MOF market's trajectory, key drivers, and what the future may hold for this evolving industry.

Market Dynamics: A Rapidly Expanding Sector

The global Metal Organic Frameworks market is expected to witness strong growth in the coming years. It is estimated at USD 0.51 billion in 2024 and is projected to reach USD 1.70 billion by 2030, at a CAGR of 22.1% from 2024 to 2030. The primary drivers of this growth are the increasing applications of MOFs in diverse industries and their unique capabilities in addressing critical challenges related to energy storage, environmental sustainability, and advanced materials.

The adaptability of MOFs, particularly their ability to be customized based on the application, is a key factor driving their adoption. Their extensive internal surface area and tunable pore sizes make them ideal for gas storage applications, including hydrogen and methane storage, where efficiency and space optimization are paramount. The chemical and oil & gas industries are also benefiting from MOF technologies in gas separation processes, leading to cost savings and enhanced environmental performance.

Beyond gas-related applications, MOFs are finding increasing use in the pharmaceutical sector, where they are employed for controlled drug release and delivery. Additionally, their potential for catalysis in chemical reactions is opening up new avenues in industrial chemical processes. As industries are compelled to adopt more sustainable practices due to stringent environmental regulations, MOFs are playing a vital role in areas such as carbon capture and water treatment, further driving their market demand.

Key Growth Drivers in the MOF Market

Sustainability and Environmental RegulationsA significant factor driving the expansion of the MOF market is the global focus on sustainability. Governments and regulatory bodies worldwide are enforcing stricter environmental laws to combat climate change and reduce emissions. MOFs, with their capacity to absorb gases such as carbon dioxide, are gaining attention as an essential material in carbon capture and storage (CCS) technologies. Industries such as oil & gas and energy are increasingly exploring MOF applications to meet regulatory requirements and lower their carbon footprint, particularly in the area of post-combustion carbon capture.

Rising Demand for Efficient Energy StorageAs the world shifts towards renewable energy sources, the need for efficient energy storage technologies is rising. MOFs are emerging as an ideal solution for storing hydrogen, a critical component for the future of clean energy, especially in fuel cells. MOFs offer higher storage capacity compared to traditional materials, allowing industries to improve the efficiency of energy storage systems. The transportation and automotive industries, in particular, are exploring MOF-based solutions to enhance the performance of hydrogen fuel cells, which is expected to be a key driver of market growth.

Advancements in Healthcare and Drug DeliveryThe healthcare industry is another promising area for MOF applications. MOFs are being used in drug delivery systems due to their ability to encapsulate therapeutic agents, enabling precise and controlled release over time. This capability makes them highly desirable in the development of new pharmaceutical treatments, particularly in personalized medicine. The demand for advanced drug delivery mechanisms is fueling research into the use of MOFs for safe, efficient, and targeted drug administration.

Industry Challenges: Addressing Barriers to Adoption

While the outlook for the MOF market is positive, there are several challenges that need to be addressed to ensure sustained growth and widespread adoption. One of the most significant hurdles is the high cost associated with the synthesis of MOFs. Producing these materials at an industrial scale requires expensive raw materials and complex manufacturing processes, which can limit their commercial viability. The development of cost-effective synthesis methods is a critical area of ongoing research, as reducing production costs will be essential to unlocking the broader potential of MOFs.

Another challenge is the lack of standardization within the MOF industry. Given the wide variety of MOFs and their customizable properties, there is currently no universal standard for the production, characterization, and performance of these materials. This variability can create inconsistencies in the quality and effectiveness of MOFs, especially when scaling up production for commercial use. Industry-wide standards and best practices will be necessary to facilitate the adoption of MOFs across sectors.

Furthermore, the long-term stability of MOFs in real-world applications remains a concern. In industrial applications such as gas storage and separation, MOFs must maintain their structural integrity and performance over extended periods of time and under varying environmental conditions. Continued research is needed to improve the durability and resilience of MOFs, ensuring they can meet the rigorous demands of industrial use.

Competitive Landscape and Regional Trends

The competitive landscape of the MOF market is highly dynamic, with several key players making strides in developing and commercializing MOF-based technologies. Notable companies in the market include BASF SE, MOF Technologies, NuMat Technologies, and Strem Chemicals, Inc. These companies are investing heavily in research and development to create MOFs with tailored properties for specific industrial applications. Collaboration between MOF producers, end-users, and research institutions is crucial in driving innovation and accelerating the commercialization of MOF technologies.

Geographically, North America and Europe are leading the market in terms of research and development activities, particularly in the environmental and energy sectors. The United States and Europe are witnessing strong investments in MOF-based carbon capture and air purification technologies. Meanwhile, the Asia-Pacific region is expected to emerge as a significant growth area in the coming years due to its rapidly expanding industrial base and increasing demand for clean energy solutions.

Future Prospects: Innovation and Collaboration as Key Drivers

Looking ahead, the future of the MOF market will be shaped by continued innovation and strategic collaboration across industries. Companies that focus on reducing production costs, improving material performance, and standardization MOF production processes will be well-positioned to capture market share. Additionally, partnerships between MOF producers and key industries—such as energy, healthcare, and chemicals—will drive the development of new applications and business opportunities.

Investment in R&D is critical to advancing the field and overcoming current limitations. Breakthroughs in computational modeling and material design are expected to accelerate the discovery of new MOF structures tailored for specific applications. As the market matures, regulatory support, government funding, and collaborative efforts will play an essential role in pushing the boundaries of what MOFs can achieve.

To gain deeper insights, download the PDF brochure : 

The global Metal Organic Frameworks market presents a wealth of opportunities for innovation and growth, driven by the increasing demand for sustainable solutions in key industries. Despite the challenges, the market is set to expand significantly over the next decade, offering significant value for industry leaders who invest in MOF technology and capitalize on its potential to revolutionize the future of materials science.

[robjackson616-blog]

Electronic Vehicle Market Growth Now and Beyond

According to HTF Market Intelligence, theGlobal Electronic Vehicle market to witness a CAGR of 22.1% during forecast period of 2024-2030. Global Electronic Vehicle Market Breakdown by Component (Battery Cells & Packs, On-Board Charge, Motor, Reducer, Fuel Stack, Others) by Vehicle Type (Passenger Cars, Commercial Vehicles, Two-Wheelers, E-Scooters & Bikes, Light Commercial Vehicles, Others) by Propulsion Type (Hybrid Vehicles, Battery Electric Vehicles, Fuel Cell Electric Vehicles) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Electronic Vehicle market size is estimated to increase by USD      Billion at a CAGR of 22.1% from 2024 to 2030.. Currently, market value is pegged at USD 438.7 Billion.

Get Detailed TOC and Overview of Report @

An electronic car, commonly known as an electric car or EV (Electric Vehicle), is a type of automobile that uses electric motors for propulsion, relying on energy stored in rechargeable batteries or another energy storage device. Unlike traditional internal combustion engine vehicles, electronic cars produce zero tailpipe emissions.

Some of the key players profiled in the study are Tesla (United States), BYD (China), BMW (Germany), Volkswagen (Germany), Nissan (Japan), Bayerische Motoren Werke Aktiengesellchaft (Germany), Daimler AG (Germany), Energica Motor Company S.p.A. (Italy), Ford Motor Company (United States), General Motor Company (United States)..    

Book Latest Edition of Global Electronic Vehicle Market Study @ https://www.htfmarketintelligence.com/buy-now?format=1&report=908

About Us:

HTF Market Intelligence is a leading market research company providing end-to-end syndicated and custom market reports, consulting services, and insightful information across the globe. HTF MI integrates History, Trends, and Forecasts to identify the highest value opportunities, cope with the most critical business challenges and transform the businesses. Analysts at HTF MI focuses on comprehending the unique needs of each client to deliver insights that are most suited to his particular requirements.

Contact Us:

Craig Francis (PR & Marketing Manager) HTF Market Intelligence Consulting Private Limited Phone: +15075562445 sales@htfmarketintelligence.com

[got-into-worm-by-mistake]

Odd, to think how much time I’d dedicated to Dinah, and how little I really knew her. 

It is honestly a mite insane when you think about, the lengths Taylor went to just for Dinah, just for one girl. She pinned her entire sense of 'I'm still a good person on the inside, where it counts' on rescuing Dinah, and... well, that's just never a good way to do things.

[yes-bernie-stuff]

Notre Pâque 25/03/2024

La fête des pains sans levain, appelée la Pâque, approchait. Luc 22.1

Neuf plaies divines ont déjà frappé l’Égypte qui tient le peuple d’Israël en esclavage ! En frappant tous les premiers-nés du pays, Dieu apportera par ce dixième fléau la délivrance des Israélites.

Il demande à chaque famille des captifs de sacrifier la veille au soir un agneau et de recueillir son sang pour en badigeonner les montants de la porte d’entrée. L’ange de Dieu frappera le pays dans la nuit, mais quand il verra ce signe sur une maison, il passera au-dessus (passa’h) pour épargner¹ les fils aînés réfugiés à l’intérieur.

Dieu prescrivit de manger l’agneau rôti au feu en étant debout, prêts à partir, le bâton à la main, les sandales aux pieds. Il commanda que les pains préparés pour ce dernier repas soient cuits à la hâte sans attendre que la pâte ait levé².

C’est pourquoi la célébration de la libération du peuple d’Israël sous la conduite de Moïse, se nomme la fête des pains sans levain ou celle de la Pâque, de l’hébreu Pessa’h ¹.

Or, lors de cette commémoration à Jérusalem, la veille au soir de sa crucifixion, Christ annonce à ses disciples son sacrifice pour sauver tous ceux qui croiraient en Lui. Jésus se présente comme l’Agneau de Dieu qui délivre de l’esclavage du péché ! Son sang sur la croix marque l’accomplissement³ de notre délivrance, notre Pâque.

Dominique Moreau

¹ Pessa’h : épargner, passer outre ² voir la lecture proposée ³ Luc 22.15-16

__________________ Lecture proposée : Livre de l’Exode, chapitre 12, versets 1 à 14.

1 L'Éternel dit à Moïse et à Aaron dans le pays d'Égypte:

2 Ce mois-ci sera pour vous le premier des mois; il sera pour vous le premier des mois de l'année.

3 Parlez à toute l'assemblée d'Israël, et dites: Le dixième jour de ce mois, on prendra un agneau pour chaque famille, un agneau pour chaque maison.

4 Si la maison est trop peu nombreuse pour un agneau, on le prendra avec son plus proche voisin, selon le nombre des personnes; vous compterez pour cet agneau d'après ce que chacun peut manger.

5 Ce sera un agneau sans défaut, mâle, âgé d'un an; vous pourrez prendre un agneau ou un chevreau.

6 Vous le garderez jusqu'au quatorzième jour de ce mois; et toute l'assemblée d'Israël l'immolera entre les deux soirs.

7 On prendra de son sang, et on en mettra sur les deux poteaux et sur le linteau de la porte des maisons où on le mangera.

8 Cette même nuit, on en mangera la chair, rôtie au feu; on la mangera avec des pains sans levain et des herbes amères.

9 Vous ne le mangerez point à demi cuit et bouilli dans l'eau; mais il sera rôti au feu, avec la tête, les jambes et l'intérieur.

10 Vous n'en laisserez rien jusqu'au matin; et, s'il en reste quelque chose le matin, vous le brûlerez au feu.

11 Quand vous le mangerez, vous aurez vos reins ceints, vos souliers aux pieds, et votre bâton à la main; et vous le mangerez à la hâte. C'est la Pâque de l'Éternel.

12 Cette nuit-là, je passerai dans le pays d'Égypte, et je frapperai tous les premiers-nés du pays d'Égypte, depuis les hommes jusqu'aux animaux, et j'exercerai des jugements contre tous les dieux de l'Égypte. Je suis l'Éternel.

13 Le sang vous servira de signe sur les maisons où vous serez; je verrai le sang, et je passerai par-dessus vous, et il n'y aura point de plaie qui vous détruise, quand je frapperai le pays d'Égypte.

14 Vous conserverez le souvenir de ce jour, et vous le célébrerez par une fête en l'honneur de l'Éternel; vous le célébrerez comme une loi perpétuelle pour vos descendants.

[covid-safer-hotties]

Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation - Published Sept 14, 2024

Abstract Patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) are highly susceptible to infections. The consequent use of masks on wards for allo-HSCT has been controversial in the past decades and was not common before the COVID-19 pandemic. We retrospectively compared incidence and outcomes of viral respiratory infections during allo-HSCT on our specialized ward between 01/2018 and 09/2020 to the era of FFP2 masking between 10/2020 and 10/2022 covering similar seasons of the year. Each group consisted of 150 matched patients. The usage of FFP2 masks reduced the incidence of viral respiratory infections from 22.1 to 2.1% (p < 0.005). This reduced the time on ward from a median of 26 days to 23.5 days (p = 0.002). It also resulted in less use of CT-scans (p = 0.003) and bronchoalveolar lavage procedures (p = 0.057). Median time to proof of infection was 21 days after admission in both groups. No difference was detected in progression free survival, hospital survival or non-relapse mortality (p = 0.78). Our retrospective results indicate that FFP2 masks worn by patients and hospital staff may help to significantly reduce the incidence of viral respiratory infections, including COVID-19, shorten the in-hospital time, and reduce costs without affecting survival.

[delvenservices]

Single-use Bioreactors Market Growth Opportunities & key Player: 2028

Single-use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

The global single-use bioreactors market is projected to reach USD 3.4 billion in 2021, at a CAGR of 22.1% during the forecast period, 2021-2028.

Single-use bioreactors is self-contained and preassembled plastic fluid pathways made from a mix of standard components that are generally gamma-irradiated for sterility and ready-to-use. single-use assemblies can be customized to fit specific applications and unit activities.

Increasing adoption of SUBs among small companies and start-ups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are some of the factors that have supported long-term expansion for Single-use Bioreactors Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. Manufacturers are facing sudden challenges caused by the crisis.

Request For Free Sample Report: https://www.delvens.com/get-free-sample/single-use-bioreactors-market-trends-forecast-till-2028

Regional Analysis

North America accounted for the largest share of the single-use bioreactors market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of established biopharmaceutical industry and the presence of major players operating in the single-use bioreactors market in North America.

Key Players

Sartorius AG

Thermo Fisher Scientific

Danaher Corporation

Merck KGaA

Avantor Inc

GE Healthcare

Parker Hannifin Corporation

Saint-Gobain

Recent Developments

In 2020, Sartorius Stedim Biotech (France) launched BIOSTAT STR Generation 3 Single-Use Bioreactor

In 2019, Pall Corporation (US) entered into a partnership with Freeline (UK) to implement its iCELLis bioreactor system in the Freeline’s adeno-associated virus (AAV) manufacturing platform. This partnership aims to achieve commercial scale and quality production of AAV gene therapy vectors.

Make an Inquiry Before the Purchase: https://www.delvens.com/Inquire-before-buying/single-use-bioreactors-market-trends-forecast-till-2028

Reasons to Acquire

Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors

Gain authentic and granular data access for Single-use Bioreactors Market so as to understand the trends and the factors involved behind changing market situations

Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future

In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Purchase this Report at: https://www.delvens.com/checkout/single-use-bioreactors-market-trends-forecast-till-2028

Report Scope

Single-use Bioreactors Market is segmented into product, type, type of cell, molecule type, application, end user and region.

On the basis of Product

Single use bioreactor systems

Single use media bags

Single use filtration assemblies

On the basis of Type

Stirred-tank SUBs

Wave-induced SUBs

Bubble-column SUBs

Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)

On the basis of type of Cell

Mammalian Cells

Bacterial Cells

Yeast Cells

Other Cells (Insect and plant cells)

On the basis of Molecule Type

Monoclonal Antibodies

Vaccines

Gene-modified cells

Stem Cells

Other Molecules (Recombinant proteins including growth factors & interferons, antisense, RNA interference and others)

 On the basis of Application

Research and Development (R&D)

Process Development

Bioproduction

On the basis of End-User

Pharmaceutical & Biopharmaceutical Companies

CROs & CMOs

Academic & Research Institutes

On the basis of Region

Asia Pacific

North America

Europe

South America

Middle East & Africa

Read Industry Related Report:

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

[universe-on-her-shoulders]

I posted 6,107 times in 2021

264 posts created (4%)

5843 posts reblogged (96%)

For every post I created, I reblogged 22.1 posts.

I added 5,497 tags in 2021

#thirteenth doctor - 1113 posts

#torchwood - 743 posts

#tenth doctor - 605 posts

#clara oswald - 494 posts

#eleventh doctor - 454 posts

#yasmin khan - 450 posts

#twelfth doctor - 444 posts

#captain jack harkness - 428 posts

#dw spoilers - 426 posts

#ianto jones - 340 posts

Longest Tag: 116 characters

#i would love to talk about it with you please feel free to message me on here or leave long rambling comments on ao3

My Top Posts in 2021

#5

I'm just imagining now everyone else who had found out the doctor was in space jail... And had elaborate break out plans (clara. River) and find out that jack broke her out. They're going to have words.

About a week after the Doctor gets broken out, I’m just imagining River and Clara smashing their way into her cell like “SURPRI- WHERE THE HELL IS SHE?” and scaring the living daylights out of the poor alien who’s been assigned it. (Like it wasn’t weird enough with all the tally marks on the walls.)

158 notes • Posted 2021-01-03 20:18:15 GMT

#4

Look, I just want a West Wing meets The Thick of It type Doctor Who spinoff featuring the exasperated civil servants of the UK trying to cope with the copious amounts of alien-related shit the government keeps encountering (World War Three, Harry Saxon, Doomsday, The Stolen Earth, the Moon’s an egg, In The Forest of the Night, the Zygon uprising/assimilation, the Monks, Praxeus, the 456, Miracle Day, etc.), featuring them having weekly office whip-rounds and bake sales to try and raise money for Torchwood and UNIT after they get defunded following Brexit, because nobody else seems to have a clue what’s going on and they’re sick of having to fill out forms.

192 notes • Posted 2021-02-15 23:18:49 GMT

#3

Michael Sheen is an absolute mood.

224 notes • Posted 2021-01-05 19:53:57 GMT

#2

Does the Translation Circuit still work if the Doctor is millions of light years away from the TARDIS or was the Doctor just walking around Judoon maximum security speaking Gallifreyan, confusing the hell out of everyone?

284 notes • Posted 2021-01-03 13:06:04 GMT

#1

Doctor Who Showrunners be like: *slaps the Doctor’s shoulder* this bad boy can fit so much emotional trauma and repressed PTSD

736 notes • Posted 2021-01-03 20:28:27 GMT

Get your Tumblr 2021 Year in Review →

[n0manisan]

I just bought the Incredi-files, and while most of the info isn't new, it does provide interesting little details like: 

 Dynaguy was sued for $1 million in emotional distress because he didn't save a kid's teddy bear while rescuing her and her family from a fire. He did replace the teddy bear though

The Parr's previous addresses are difficult to decipher because they’re crossed out (thus anything i can't read is replaced with a blank) but to the best of my ability they are:

1107 Madison Avenue, _____ Hill, CA, _____

310 Mackenze Street, _____, CA, _4556

 __67 Avery Way, _afay _____, CA, _454_

Helen runs a carpool, along with Beth Giles and Dovie Ramsey to pick up Dash, Jacob, Jordyn, Kai, Taidan, Lucy, Devin, Ben, Madison, and Mackenzie. Helen drives on Mondays. Assuming they are the same person, Ben is one of Violet's classmates 

As Elastigirl, Helen wrote a newspaper article about shopping tips

The Happy Platter serves cheesy buffalo wings

Dash ran at 475 mph when he placed the tack on Bernie's chair, and was running at least 85 mph on water. Evelyn estimates that his top speed will increase as he gets older, and may be able to break the sound barrier

Evelyn has suggested putting a surveillance team on Dash's track coach because he's getting suspicious about Dash's constant second place finishes. Bernie is also under surveillance 

Jack Jack has acute hearing, taste, and has super intellect (supposedly, but not confirmed)

Devtech has a childcare center and Winston wants to use Jack Jack to market a utility belt meant to hold baby supplies

Lucius has a clothing line and a career in the music industry

Lucius also wishes he had a car like the Incredibile

Before the deaths of Thunderhead, Metaman, Splashdown, Dynaguy, and Stratogale capes were considered standard issue

People without powers are called non-super individuals (NSIs)

Ironically, the charge Mr. Incredible was brought to court for was endangering the life of a despondent citizen

The fabric Edna uses is called haluminum vibronic dacralor polymesh

Edna is said to have abandoned capes, meaning that she has designed them in the past, and she is the first to pioneer capeless designs

Edna's studio is located in her basement

Most villains began pursuing legitimate lines of work after the Super ban 

 Mirage is not Mirage's real name (though her real name is unknown) 

 Due to Mirage's surveillance equipment, we know that Mirage spotted Bob and Lucius at 11:46 pm 

 The Incredibile's top speed is 300mph, while the Elasticycle's top speed is 200mph

The Elasticycle runs on two solar-hydrogen hybrid fuel cells

Fewer commuters rely on the monorail because of how many incidents there have been involving them

The mind wiping device that Rick uses is called the MW-086 Decerebralator, and there are only two in existance. Rick intends to repurpose or dismantle it when the Superhero Relocation Act is repealed 

Evelyn's hypo-goggles can project holograms, augmented reality, and virtual reality. Also Winston doesn't like how they look

Jack Jack's baby monitor tracks the supply of cookies and diapers and automatically places an order when the supply runs too low

Kari is under surveillance by the NSA

Jack Jack weighs 22.1 lbs

The book is not written by Brad Bird (it is instead written by John Edwards) so this information is debatable canon, but I’m just putting it out here so you can decide for yourselves.